Search This Blog

Monday, August 3, 2020

Freeline Therapeutics sets IPO terms

Freeline Therapeutics (FRLN) has launched the roadshow for its IPO of up to 7,352,941 American Depositary Shares (ADSs).
The price is currently expected to be between $16.00 and $18.00 per ADS, resulting in a total offering size of $117.6M to $132.4M.
Underwriters’ over-allotment is an additional 1,102,941 ADSs.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.